Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Saverio Minucci

Showing results (131-140 of 169) with videos related to

Pageof 17
Sort By:
Cytokine & Growth Factor Reviews|February 21, 2021
Anticancer innovative therapy congress: Highlights from the 10th anniversary editionFrancesca De Santis, Giovanni Fucà, Dirk Schadendorf, et al.
Nature Structural & Molecular Biology|November 7, 2022
Endocrine resistance and breast cancer plasticity are controlled by CoRESTLiliana Garcia-Martinez, Andrew M Adams, Ho Lam Chan, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 3, 2026
Spatiotemporal Atlas of Pro-Inflammatory NF-κB and Anti-Inflammatory STAT6 Signalling Using Reporter Mice during mRNA VaccinationElectra Brunialti, Alessia Panzeri, Nicoletta Rizzi, et al.
Nature Genetics|May 27, 2017
Corrigendum: Acquired CYP19A1 amplification is an early specific mechanism of aromatase inhibitor resistance in ERα metastatic breast cancerLuca Magnani, Gianmaria Frigè, Raffaella Maria Gadaleta, et al.
Nature Genetics|January 24, 2017
Acquired CYP19A1 amplification is an early specific mechanism of aromatase inhibitor resistance in ERα metastatic breast cancerLuca Magnani, Gianmaria Frige, Raffaella Maria Gadaleta, et al.
Nature Communications|November 28, 2015
Differential epigenetic reprogramming in response to specific endocrine therapies promotes cholesterol biosynthesis and cellular invasionVan T M Nguyen, Iros Barozzi, Monica Faronato, et al.
Science Translational Medicine|December 8, 2021
LSD1-directed therapy affects glioblastoma tumorigenicity by deregulating the protective ATF4-dependent integrated stress responseStefania Faletti, Daniela Osti, Elena Ceccacci, et al.
Nanoscale Horizons|May 22, 2024
Biocompatible cellulose nanocrystal-based Trojan horse enables targeted delivery of nano-Au radiosensitizers to triple negative breast cancer cellsGiacomo Biagiotti, Riccardo Cazzoli, Patrizia Andreozzi, et al.
Genes & Development|April 1, 2014
HDAC-regulated myomiRs control BAF60 variant exchange and direct the functional phenotype of fibro-adipogenic progenitors in dystrophic musclesValentina Saccone, Silvia Consalvi, Lorenzo Giordani, et al.
ACS Medicinal Chemistry Letters|May 22, 2020
Discovery of Reversible Inhibitors of KDM1A Efficacious in Acute Myeloid Leukemia ModelsAlessia Romussi, Anna Cappa, Paola Vianello, et al.
Pageof 17

Showing results (131-140 of 169) with videos related to

Sort By:
Pageof 17
Cytokine & Growth Factor Reviews|February 21, 2021
Anticancer innovative therapy congress: Highlights from the 10th anniversary editionFrancesca De Santis, Giovanni Fucà, Dirk Schadendorf, et al.
Nature Structural & Molecular Biology|November 7, 2022
Endocrine resistance and breast cancer plasticity are controlled by CoRESTLiliana Garcia-Martinez, Andrew M Adams, Ho Lam Chan, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 3, 2026
Spatiotemporal Atlas of Pro-Inflammatory NF-κB and Anti-Inflammatory STAT6 Signalling Using Reporter Mice during mRNA VaccinationElectra Brunialti, Alessia Panzeri, Nicoletta Rizzi, et al.
Nature Genetics|May 27, 2017
Corrigendum: Acquired CYP19A1 amplification is an early specific mechanism of aromatase inhibitor resistance in ERα metastatic breast cancerLuca Magnani, Gianmaria Frigè, Raffaella Maria Gadaleta, et al.
Nature Genetics|January 24, 2017
Acquired CYP19A1 amplification is an early specific mechanism of aromatase inhibitor resistance in ERα metastatic breast cancerLuca Magnani, Gianmaria Frige, Raffaella Maria Gadaleta, et al.
Nature Communications|November 28, 2015
Differential epigenetic reprogramming in response to specific endocrine therapies promotes cholesterol biosynthesis and cellular invasionVan T M Nguyen, Iros Barozzi, Monica Faronato, et al.
Science Translational Medicine|December 8, 2021
LSD1-directed therapy affects glioblastoma tumorigenicity by deregulating the protective ATF4-dependent integrated stress responseStefania Faletti, Daniela Osti, Elena Ceccacci, et al.
Nanoscale Horizons|May 22, 2024
Biocompatible cellulose nanocrystal-based Trojan horse enables targeted delivery of nano-Au radiosensitizers to triple negative breast cancer cellsGiacomo Biagiotti, Riccardo Cazzoli, Patrizia Andreozzi, et al.
Genes & Development|April 1, 2014
HDAC-regulated myomiRs control BAF60 variant exchange and direct the functional phenotype of fibro-adipogenic progenitors in dystrophic musclesValentina Saccone, Silvia Consalvi, Lorenzo Giordani, et al.
ACS Medicinal Chemistry Letters|May 22, 2020
Discovery of Reversible Inhibitors of KDM1A Efficacious in Acute Myeloid Leukemia ModelsAlessia Romussi, Anna Cappa, Paola Vianello, et al.
Pageof 17